The HEALWELL Ecosystem
Transforming Healthcare and Lives: AI-Driven Early Disease Detection

Who We Are
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Our mission is to improve healthcare and save lives through early identification and detection of disease.
Using our proprietary AI technology and competencies, including data science, electronic health records, and clinical research offerings, HEALWELL is developing and commercializing advanced clinical decision support systems. These tools help healthcare providers detect rare and chronic diseases, improve the efficiency of their practice, and ultimately help improve patient health outcomes.

The HEALWELL AI Ecosystem
The HEALWELL Ecosystem is currently comprised of seven synergistic companies. These include best-in-class healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services.
Healthcare Artificial Intelligence Technologies
High Growth, Re-occurring Revenue with 70+% Gross Margins.
- Rare and Chronic Disease Screening (Patient Risk Stratification)
- Real World Evidence (RWE) Clinical Study Generation
- Advanced Clinical Decision Support
- Physician AI Co-pilot Tools
Supports:
- Pharmaceutical Companies
- Life Science Companies
- Precision Medicine Companies
Electronic Health Record Software and Healthcare Data Management
SaaS Revenue Model with 60+% Gross Margins and EBITDA Positive.
- Clinical Workstation & EHR Software
- Data Interoperability & Management Solutions
- Data Transformation and Systems Integration
- Population Health Management
- Digital Front Doors (Patient Engagement Platforms)
Supports:
- Global Public Sector
- Healthcare Providers
- Health Systems
Contract Research and Clinical Trial Services
Per-Visit or Per-Project Revenue Model with 20+% Gross Margins and EBITDA Positive.
- Full Service, Early Stage Bioanalysis, Bioequivalence and Phase I Trials
- Phase II-IV Clinical Trials
- Clinical Trial Design & Architecture Services
Supports:
- Government Reimbursement
- Health Insurance Companies
- Life Science Research

Strategic Focus
HEALWELL is executing a strategy centered around artificial intelligence and clinical sciences capabilities for preventative care. One of the main strategic initiatives of HEALWELL is to be a capital allocator and rapidly grow through acquisition. To date, we have successfully completed four material transactions and completed a minority investment.
From an M&A perspective, HEALWELL is focused on two synergistic buckets. The first is to acquire other AI early disease detection-oriented companies. The second is to acquire mature operating healthcare software and research companies that bring in strong financial fundamentals and an opportunity to ameliorate with our complementary AI technology.
The HEALWELL + WELL Health Growth Advantage
WELL Health (TSX: WELL), our lead investor and exclusive strategic partner, is Canadaās most consequential healthcare provider and omni-channel outpatient medical clinic provider, providing HEALWELL with a vast distribution channel that helps power organic growth.
WELL Health provides the company with strategic access to more consenting clinicians than any other AI business in Canada.
This access allows HEALWELL to continually refine our algorithms, further positioning HEALWELL as the leading force in disease detection software and preventative healthcare.
Similar to WELL, HEALWELL has a robust M&A strategy and pipeline that is helping to rapidly scale the business.
WELL Health's Scale
#1 Digital Healthcare Ecosystem in Canada
In partnership with WELL Health, HEALWELL has access to Canadaās leading EMR app ecosystem and over 40k providers.